Moderna COVID-19 vaccine gets emergency use authorisation in the US Associated Press
Washington: The US Food and Drug Administration’s (FDA) advisory panel, comprising external experts, has given an emergency use approval to Moderna COVID-19 vaccine. It is the second COVID-19 vaccine after Pfizer to receive such an authorisation in less than a week.
FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC), made up of independent scientific and public health experts, at its meeting Thursday voted 20-0 with one abstention to recommend emergency use authorization for the Moderna COVID-19 vaccine mRNA-1273.
The FDA allowed last Friday the emergency use of the country’s first COVID-19 vaccine developed by Pfizer and BioNTech. The US is desperately trying to combat the disease that has killed over 310,000 people.
Updated:
Share Article
AAA
FILE PHOTO: The Moderna vaccine uses similar messenger RNA technology but with less onerous cold storage requirements than the Pfizer/BioNTech shot.
| Photo Credit:
REUTERS The US Food and Drug Administration’s advisory panel, comprising external experts, has given an emergency use approval to Moderna COVID-19 vaccine, making it the second drug after Pfizer to receive such an authorisation in less than a week. FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC), made up of independent scientific and public health experts, at its meeting on Thursday voted 20-0 with one abstention to recommend Emergency Use Authorization for the Moderna COVID-19 vaccine mRNA-1273.